Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 535


The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder.

Cao B, Park C, Subramaniapillai M, Lee Y, Iacobucci M, Mansur RB, Zuckerman H, Phan L, McIntyre RS.

Front Psychiatry. 2019 Jan 31;10:17. doi: 10.3389/fpsyt.2019.00017. eCollection 2019.


Cariprazine for the treatment of bipolar depression: a review.

Ragguett RM, McIntyre RS.

Expert Rev Neurother. 2019 Feb 12. doi: 10.1080/14737175.2019.1580571. [Epub ahead of print]


The glycine site of NMDA receptors: A target for cognitive enhancement in psychiatric disorders.

Peyrovian B, Rosenblat JD, Pan Z, Iacobucci M, Brietzke E, McIntyre RS.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Feb 6. pii: S0278-5846(18)30721-8. doi: 10.1016/j.pnpbp.2019.02.001. [Epub ahead of print] Review.


Brain insulin resistance: A treatment target for cognitive impairment and anhedonia in depression.

Hamer JA, Testani D, Mansur RB, Lee Y, Subramaniapillai M, McIntyre RS.

Exp Neurol. 2019 Jan 26;315:1-8. doi: 10.1016/j.expneurol.2019.01.016. [Epub ahead of print] Review.


Characterizing acyl-carnitine biosignatures for schizophrenia: a longitudinal pre- and post-treatment study.

Cao B, Wang D, Pan Z, Brietzke E, McIntyre RS, Musial N, Mansur RB, Subramanieapillai M, Zeng J, Huang N, Wang J.

Transl Psychiatry. 2019 Jan 17;9(1):19. doi: 10.1038/s41398-018-0353-x.


Expert Consensus on Screening and Assessment of Cognition in Psychiatry.

McIntyre RS, Anderson N, Baune BT, Brietzke E, Burdick K, Fossati P, Gorwood P, Harmer C, Harrison J, Harvey P, Mansur RB, Medalia A, Miskowiak K, Ramey T, Rong C, Rosenblat JD, Young A, Stahl SM.

CNS Spectr. 2019 Jan 15:1-9. doi: 10.1017/S1092852918001189. [Epub ahead of print]


Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review.

Cao B, Zhu J, Zuckerman H, Rosenblat JD, Brietzke E, Pan Z, Subramanieapillai M, Park C, Lee Y, McIntyre RS.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jan 3;92:109-117. doi: 10.1016/j.pnpbp.2019.01.002. [Epub ahead of print] Review.


Hypersomnia and Bipolar Disorder: A systematic review and meta-analysis of proportion.

Grigolon RB, Trevizol AP, Cerqueira RO, Lee Y, Mansur RB, McIntyre RS, Brietzke E.

J Affect Disord. 2019 Mar 1;246:659-666. doi: 10.1016/j.jad.2018.12.030. Epub 2018 Dec 18. Review.


Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies.

Thase ME, Weiller E, Zhang P, Weiss C, McIntyre RS.

Neuropsychiatr Dis Treat. 2018 Dec 20;15:37-45. doi: 10.2147/NDT.S185815. eCollection 2019.


Rapastinel - an investigational NMDA-R modulator for major depressive disorder: evidence to date.

Ragguett RM, Rong C, Kratiuk K, McIntyre RS.

Expert Opin Investig Drugs. 2019 Feb;28(2):113-119. doi: 10.1080/13543784.2019.1559295. Epub 2018 Dec 26. Review.


The effects of valbenazine on tardive dyskinesia in patients with a primary mood disorder.

McIntyre RS, Calabrese JR, Nierenberg AA, Farahmand K, Yonan C, Siegert S, Burke J.

J Affect Disord. 2019 Mar 1;246:217-223. doi: 10.1016/j.jad.2018.12.023. Epub 2018 Dec 17.


A pilot case-control study on the association between N-acetyl derivatives in serum and first-episode schizophrenia.

Huang N, Cao B, Brietzke E, Park C, Cha D, Pan Z, Zhu J, Liu Y, Xie Q, Zeng J, McIntyre RS, Wang J, Yan L.

Psychiatry Res. 2018 Dec 6;272:36-41. doi: 10.1016/j.psychres.2018.11.064. [Epub ahead of print]


Evaluating the role of orexins in the pathophysiology and treatment of depression: A comprehensive review.

Shariq AS, Rosenblat JD, Alageel A, Mansur RB, Rong C, Ho RC, Ragguett RM, Pan Z, Brietzke E, McIntyre RS.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Dec 18;92:1-7. doi: 10.1016/j.pnpbp.2018.12.008. [Epub ahead of print] Review.


Recognition and Treatment of Cognitive Dysfunction in Major Depressive Disorder.

Zuckerman H, Pan Z, Park C, Brietzke E, Musial N, Shariq AS, Iacobucci M, Yim SJ, Lui LMW, Rong C, McIntyre RS.

Front Psychiatry. 2018 Dec 4;9:655. doi: 10.3389/fpsyt.2018.00655. eCollection 2018. Review.


Anti-cytokine agents for anhedonia: targeting inflammation and the immune system to treat dimensional disturbances in depression.

Lee Y, Subramaniapillai M, Brietzke E, Mansur RB, Ho RC, Yim SJ, McIntyre RS.

Ther Adv Psychopharmacol. 2018 Nov 19;8(12):337-348. doi: 10.1177/2045125318791944. eCollection 2018 Dec. Review.


Brain structural networks and connectomes: the brain-obesity interface and its impact on mental health.

Chen VC, Liu YC, Chao SH, McIntyre RS, Cha DS, Lee Y, Weng JC.

Neuropsychiatr Dis Treat. 2018 Nov 26;14:3199-3208. doi: 10.2147/NDT.S180569. eCollection 2018.


Thirty-year cardiovascular risk score in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives.

Coello K, Kjærstad HL, Stanislaus S, Melbye S, Faurholt-Jepsen M, Miskowiak KW, McIntyre RS, Vinberg M, Kessing LV, Munkholm K.

Aust N Z J Psychiatry. 2018 Dec 5:4867418815987. doi: 10.1177/0004867418815987. [Epub ahead of print]


Cognitive impairment in major depressive disorder.

Pan Z, Park C, Brietzke E, Zuckerman H, Rong C, Mansur RB, Fus D, Subramaniapillai M, Lee Y, McIntyre RS.

CNS Spectr. 2018 Nov 23:1-8. doi: 10.1017/S1092852918001207. [Epub ahead of print]


Comparison of serum essential trace metals between patients with schizophrenia and healthy controls.

Cao B, Yan L, Ma J, Jin M, Park C, Nozari Y, Kazmierczak OP, Zuckerman H, Lee Y, Pan Z, Brietzke E, McIntyre RS, Lui LMW, Li N, Wang J.

J Trace Elem Med Biol. 2019 Jan;51:79-85. doi: 10.1016/j.jtemb.2018.10.009. Epub 2018 Oct 5.


Factors That Impact Treatment Decisions: Results From an Online Survey of Individuals With Bipolar and Unipolar Depression.

Rosenblat JD, Simon GE, Sachs GS, Deetz I, Doederlein A, DePeralta D, Dean MM, McIntyre RS.

Prim Care Companion CNS Disord. 2018 Nov 1;20(6). pii: 18m02340. doi: 10.4088/PCC.18m02340.

Supplemental Content

Loading ...
Support Center